KORU Medical Systems, Inc. financial data

Symbol
KRMD on Nasdaq
Location
Mahwah, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 260% % -31%
Quick Ratio 50% % -21%
Debt-to-equity 62% % 35%
Return On Equity -22% % 64%
Return On Assets -14% % 68%
Operating Margin -10% % 53%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46,322,655 shares 1.1%
Common Stock, Shares, Outstanding 46,293,192 shares 1%
Entity Public Float $83,518,701 USD -25%
Common Stock, Value, Issued $497,137 USD 0.89%
Weighted Average Number of Shares Outstanding, Basic 45,981,826 shares 0.59%
Weighted Average Number of Shares Outstanding, Diluted 46,238,819 shares 0.85%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $39,070,637 USD 22%
Research and Development Expense $4,356,696 USD -20%
Operating Income (Loss) $4,014,873 USD 43%
Nonoperating Income (Expense) $322,759 USD -39%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $778,116 USD 51%
Income Tax Expense (Benefit) $150,000 USD
Net Income (Loss) Attributable to Parent $3,712,213 USD 69%
Earnings Per Share, Basic 0 USD/shares 33%
Earnings Per Share, Diluted 0 USD/shares -112%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,464,019 USD -3.9%
Accounts Receivable, after Allowance for Credit Loss, Current $5,412,004 USD 4.8%
Inventory, Net $4,411,710 USD 12%
Assets, Current $19,419,296 USD 2.6%
Property, Plant and Equipment, Net $4,235,983 USD -6.9%
Operating Lease, Right-of-Use Asset $2,667,656 USD -13%
Other Assets, Noncurrent $98,970 USD 0%
Assets $27,103,526 USD -1%
Accounts Payable, Current $1,872,162 USD 12%
Employee-related Liabilities, Current $456,066 USD -41%
Accrued Liabilities, Current $4,634,183 USD 66%
Liabilities, Current $7,833,932 USD 24%
Operating Lease, Liability, Noncurrent $2,688,490 USD -13%
Liabilities $10,638,701 USD 10%
Retained Earnings (Accumulated Deficit) $31,529,976 USD -13%
Stockholders' Equity Attributable to Parent $16,464,825 USD -7.2%
Liabilities and Equity $27,103,526 USD -1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $237,467 USD 32%
Net Cash Provided by (Used in) Financing Activities $160,808 USD 12%
Net Cash Provided by (Used in) Investing Activities $446,838 USD -236%
Common Stock, Shares Authorized 75,000,000 shares 0%
Common Stock, Shares, Issued 49,713,694 shares 0.89%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $845,113 USD -28%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,385 USD -56%
Deferred Tax Assets, Valuation Allowance $7,080,843 USD 18%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $8,317,035 USD 20%
Operating Lease, Liability $3,400,661 USD -8.2%
Depreciation $227,785 USD 14%
Property, Plant and Equipment, Gross $8,283,277 USD 5%
Operating Lease, Liability, Current $413,486 USD 4.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $533,979 USD 4.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $533,979 USD 4.3%
Deferred Income Tax Expense (Benefit) $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $533,979 USD 4.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four $520,985 USD 1.7%
Operating Lease, Payments $129,363 USD 7.5%
Depreciation, Depletion and Amortization $842,780 USD -6.9%
Deferred Tax Assets, Net of Valuation Allowance $1,236,192 USD 33%